Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297920)

ARTG ID

297920

ARTG Name

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack

Sponsor

Hetero Australia Pty Ltd

ARTG Date

December 13, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Hetero Australia Pty Ltd

Sponsor Item Name

HETERO AUSTRALIA PTY LTD

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/19be25573db4ef9f8ec0750b1434d4b6.pdf

Active Ingredients

Ingredient Name

abacavir sulfate

Ingredient Name

lamivudine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy